معرفی
Christopher T. Gregg is a tenured Associate Professor in the Department of Neurobiology and Adjunct Professor in Human Genetics at the University of Utah School of Medicine. His research integrates genomics, machine learning, and neurobiology to investigate gene regulatory mechanisms underlying brain function, behavior, and disease.
Education:
- BSc, University of Lethbridge
- PhD, Hotchkiss Brain Institute, University of Calgary
- Postdoctoral Fellow, Harvard University
- Certificate, Cold Spring Harbor Laboratory (x2)
Dr. Gregg's research spans four interconnected domains: (1) discovering conserved cis-regulatory elements through evolutionary genomics of species with 'biomedical superpowers'; (2) investigating non-canonical genomic imprinting and random allelic expression in the brain; (3) developing computational methods for 'Behavior Cartography' to map genetic influences on naturalistic decision-making; and (4) translating behavioral AI into clinical applications for cancer and neurodegenerative diseases. His work combines single-cell multi-omics, CRISPR editing, and machine learning to bridge molecular mechanisms with complex behaviors.
His publication record demonstrates consistent innovation across genomics, neurobiology, and computational methods. Recent work reveals how metabolic signals regulate gene expression in the hypothalamus, how random allelic effects create neuronal diversity, and how complex behaviors emerge from genetically controlled modules. This research program connects evolutionary adaptations to clinical applications in personalized medicine.
Scientific Recognition:
- Eppendorf winner (2010)
Dr. Gregg leads active research programs in both basic science and translational applications. He co-founded Storyline Health (www.storylinehealth.com) and the Uncharted Health Masterclass for Cancer Patients (www.unchartedhealth.org), and serves as scientific advisor for Rubicon AI and DepoIQ. His lab develops novel genome-editing technologies and AI-driven solutions for precision medicine in cancer, Alzheimer's, and mental health while maintaining strong NIH-funded basic research on gene regulation in behavior.
The Gregg Lab employs comparative genomics, single-cell multi-omics, and custom deep learning models to study trans-species adaptive responses. Current initiatives include Operation Warp Speed for Cancer and leveraging evolutionary insights to constrain cancer epigenetic diversity.
